Halozyme
HALO
268 hedge funds and large institutions have $3.53B invested in Halozyme in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 89 increasing their positions, 98 reducing their positions, and 28 closing their positions.
261% more call options, than puts
Call options by funds: $23.6M | Put options by funds: $6.53M
21% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 28
2% more funds holding
Funds holding: 264 → 268 (+4)
3% less capital invested
Capital invested by funds: $3.63B → $3.53B (-$107M)
9% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 98
1.96% less ownership
Funds ownership: 99.83% → 97.87% (-2%)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$53.2M |
| 2 |
Goldman Sachs
New York
|
+$29.5M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$24.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$15.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$35.9M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$35.1M |
| 3 |
First Eagle Investment Management
New York
|
-$28.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$18.9M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16M |
HALO Hedge Fund Activity: Q3 2020 in Review
268 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2020, worth a combined $3.53B — down 2.9% from $3.63B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new HALO positions and 28 closed out — a net gain of 6 holders — while 89 added to existing stakes and 98 trimmed.
The largest buyer was Macquarie Group, adding an estimated $53.2M. The largest seller was Artisan Partners, cutting an estimated $35.9M.
- 268 institutional investors held Halozyme (HALO) as of Q3 2020, up from 264 in Q2 2020.
- Funds reported $3.53B of Halozyme stock for Q3 2020, down 2.9% quarter-over-quarter.
- 34 funds opened new Halozyme positions in Q3 2020 and 28 closed out, a net change of +6 holders.
- The largest Halozyme buyer in Q3 2020 was Macquarie Group, an estimated $53.2M added.
- The largest Halozyme seller in Q3 2020 was Artisan Partners, an estimated $35.9M sold.
Based on aggregated 13F filings for Q3 2020.